NCT02571036 2023-12-13
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Phase 1 Completed
Deciphera Pharmaceuticals, LLC
Blueprint Medicines Corporation
University Hospital, Toulouse
University Hospital, Toulouse